Advisor Group Holdings, Inc. Pacira Bio Sciences, Inc. Transaction History

Advisor Group Holdings, Inc.

$67.1 Billion
Q3 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 2,268 shares of PCRX stock, worth $53,933. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,268

Previous 2,313 1.95%

Holding current value

$53,933

Previous $55,000 5.45%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$21.09 - $27.22 $949 - $1,224	-45 Reduced 1.95%	2,268 $58,000
Q2 2025 Sep 04, 2025	BUY	$22.91 - $27.14 $43,024 - $50,968	1,878 Added 431.72%	2,313 $55,000
Q2 2025 Aug 13, 2025	SELL	$22.91 - $27.14 $41,902 - $49,639	-1,829 Reduced 80.79%	435 $10,000
Q1 2025 May 12, 2025	BUY	$18.33 - $27.25 $26,963 - $40,084	1,471 Added 185.5%	2,264 $56,000
Q4 2024 Jun 06, 2025	SELL	$15.3 - $20.33 $17,090 - $22,708	-1,117 Reduced 49.34%	1,147 $21,000
Q4 2024 Feb 07, 2025	BUY	$15.3 - $20.33 $810 - $1,077	53 Added 7.16%	793 $14,000
Q3 2024 Nov 13, 2024	SELL	$11.7 - $28.46 $10,834 - $26,353	-926 Reduced 55.58%	740 $11,000
Q2 2024 Aug 13, 2024	SELL	$25.5 - $31.51 $27,540 - $34,030	-1,080 Reduced 39.33%	1,666 $47,000
Q1 2024 May 10, 2024	SELL	$27.7 - $35.48 $70,247 - $89,977	-2,536 Reduced 48.01%	2,746 $80,000
Q4 2023 Feb 12, 2024	SELL	$26.32 - $34.31 $17,792 - $23,193	-676 Reduced 11.35%	5,282 $178,000
Q3 2023 Nov 13, 2023	BUY	$30.68 - $40.09 $14,787 - $19,323	482 Added 8.8%	5,958 $182,000
Q2 2023 Aug 10, 2023	SELL	$36.12 - $47.5 $18,926 - $24,890	-524 Reduced 8.73%	5,476 $219,000
Q1 2023 May 12, 2023	SELL	$35.53 - $43.38 $342,367 - $418,009	-9,636 Reduced 61.63%	6,000 $244,000
Q4 2022 Feb 10, 2023	SELL	$38.19 - $57.45 $27,458 - $41,306	-719 Reduced 4.4%	15,636 $603,000
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $28,182 - $32,389	550 Added 3.48%	16,355 $868,000
Q2 2022 Aug 10, 2022	SELL	$51.49 - $81.64 $376,391 - $596,788	-7,310 Reduced 31.62%	15,805 $922,000
Q1 2022 May 04, 2022	BUY	$60.03 - $76.49 $1.01 Million - $1.29 Million	16,816 Added 266.96%	23,115 $1.76 Million
Q3 2021 Nov 05, 2021	BUY	$54.64 - $61.3 $27,811 - $31,201	509 Added 8.79%	6,299 $353,000
Q2 2021 Aug 02, 2021	SELL	$59.18 - $69.99 $2,959 - $3,499	-50 Reduced 0.86%	5,790 $354,000
Q1 2021 May 13, 2021	SELL	$59.31 - $78.82 $8,540 - $11,350	-144 Reduced 2.41%	5,840 $410,000
Q4 2020 Feb 10, 2021	SELL	$50.47 - $66.26 $6,157 - $8,083	-122 Reduced 2.0%	5,984 $359,000
Q3 2020 Nov 12, 2020	BUY	$51.97 - $63.0 $82,632 - $100,170	1,590 Added 35.21%	6,106 $367,000
Q2 2020 Aug 14, 2020	BUY	$30.8 - $52.47 $15,677 - $26,707	509 Added 12.7%	4,516 $234,000
Q1 2020 May 18, 2020	BUY	$28.4 - $50.7 $113,798 - $203,154	4,007 New	4,007 $135,000

Others Institutions Holding PCRX

# of Institutions

266

Shares Held

50M

Call Options Held

275K

Put Options Held

77.2K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.09B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Pacira Bio Sciences, Inc. Transaction History